STSSW
Price:
$0.05
Market Cap:
$5.31M
Sharps Technology Inc., a medical device company, researches, designs, develops, manufactures, distributes, and sells safety syringe products in the United States. It offers Sharps Provensa, an ultra-low waste space syringe for the administration of various vaccines and injectable medications. The company was incorporated in 2017 and is based in Melville, New York.[Read more]
Industry
Financial - Capital Markets
IPO Date
2022-04-14
Stock Exchange
NASDAQ
Ticker
STSSW
According to Sharps Technology, Inc.’s latest financial reports and current stock price. The company's current ROE is -100.70%. This represents a change of 296.34% compared to the average of -25.41% of the last 4 quarters.
The mean historical ROE of Sharps Technology, Inc. over the last ten years is -149.32%. The current -100.70% ROE has changed -32.56% with respect to the historical average. Over the past ten years (40 quarters), STSSW's ROE was at its highest in in the March 2022 quarter at 15.08%. The ROE was at its lowest in in the December 2021 quarter at -50.95%.
Average
-149.32%
Median
-124.04%
Minimum
-366.46%
Maximum
8.09%
Discovering the peaks and valleys of Sharps Technology, Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 39.85%
Maximum Annual ROE = 8.09%
Minimum Annual Increase = -1633.41%
Minimum Annual ROE = -366.46%
Year | ROE | Change |
---|---|---|
2023 | -124.04% | -1633.41% |
2022 | 8.09% | -105.25% |
2021 | -154.05% | 39.85% |
2020 | -110.15% | -69.94% |
The current ROE of Sharps Technology, Inc. (STSSW) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-90.00%
5-year avg
-149.32%
10-year avg
-149.32%
Sharps Technology, Inc.’s ROE is greater than Sharps Technology, Inc. (-100.70%), greater than Tenon Medical, Inc. (-715.68%), greater than SciSparc Ltd. (-87.48%), less than OKYO Pharma Limited (0.42%), less than Greenbrook TMS Inc. (214.61%),
Company | ROE | Market cap |
---|---|---|
-100.70% | $5.31M | |
-715.68% | $1.75M | |
-87.48% | $2.31M | |
0.42% | $39.31M | |
214.61% | $5.52M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Sharps Technology, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Sharps Technology, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is Sharps Technology, Inc.'s ROE?
How is the ROE calculated for Sharps Technology, Inc. (STSSW)?
What is the highest ROE for Sharps Technology, Inc. (STSSW)?
What is the 3-year average ROE for Sharps Technology, Inc. (STSSW)?
What is the 5-year average ROE for Sharps Technology, Inc. (STSSW)?
How does the current ROE for Sharps Technology, Inc. (STSSW) compare to its historical average?